Lidocaine Hydrochloride — Class I drug recall D-0295-2022
Ongoing recall by Teligent Pharma, Inc., reported 2022-01-05, distributed nationwide. Superpotent Drug
| Recall number | D-0295-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-11-30 |
| Classified | 2021-12-28 |
| Reported by FDA | 2022-01-05 |
| Distributed | Nationwide (US) |
| Quantity | 6,816 bottles |
| Reason classes | potency |
| NDC | 63739-0997, 63739-0997-64 |
| Lot numbers | 16345 |
| Expiration dates | 2024-01 |
Product
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64
Reason for recall
Superpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0295-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.